The Poison Factory

Researchers at Michigan State University, working with colleagues at the Czech Academy of Sciences, have mapped the complete biochemical assembly line behind atisinium — a toxic compound built by wolfsbane and larkspur — and then rebuilt that assembly line inside tobacco plants to manufacture the compound on demand. The result, published in Molecular Plant this August, gives researchers a sustainable supply of a molecule now being explored for pain relief, malaria, cancer, and agricultural pest control.

TIMELINE · two plants, one accounting problem

Reputation first, mechanism last

WOLFSBANE · aconitine and its relatives

1. < 1834Known as a poison for as long as anyone kept records. Arrow-tip and bait, then a warning in every herbal.
2. 1834Aconitine isolated (Geiger & Hesse). The finished molecule, in hand.
3. 1834–No laboratory synthesis of aconitine, through two centuries of chemistry. Still none.
4. 2026Six-enzyme pathway to atisinium — an entry compound of the same family — mapped in larkspur and wolfsbane and run inside tobacco (Miller et al.).

PACIFIC YEW · paclitaxel

1. 1962Bark collected in Washington State for the U.S. National Cancer Institute's plant screen.
2. 1971Paclitaxel isolated and its structure published (Wall & Wani).
3. 1992Approved as a cancer drug. Supply still meant yew bark or semi-synthesis from yew needles.
4. 2024–25Core pathway (to baccatin III, the drug's scaffold) rebuilt in tobacco.

In both rows the finished molecule arrives early and the instructions for building it arrive last. What closes the gap is not a new substance; it is reading a sequence of steps that was already there.

Dates: Geiger & Hesse, Ann. 1834; Wall & Wani, J. Am. Chem. Soc. 1971; FDA approval of paclitaxel, Dec 1992; Zhang et al., Science 2024 and Jiang et al., Nature 2025 (baccatin III in N. benthamiana); Miller et al., Molecular Plant 2026. The wolfsbane "reputation" band is unbounded on the left by design — it predates dated records.

Sources: ScienceDaily, Aug 1, 2026 · American Museum of Natural History, "Poison as Medicine," Nov 13, 2013

Garret P. Miller, Lana Mutabdžija-Nedelcheva, Trine B. Andersen, Imani Pascoe, Kathryn Van Winkle, Maryam Sabbaghan, Alexandre Bouillé, Tomáš Iliaš, Andrej Tekel, Tomáš Pluskal, Björn Hamberger. Characterization of the entry steps in diterpenoid alkaloid biosynthesis. Molecular Plant, 2026; DOI: 10.1016/j.molp.2026.05.022